KRAS and pancreatic neoplasm: Analysis of pancreatic cancer cell lines demonstrated that MUC1-C is overexpressed in HPAF-II (KRAS G12D) and AsPC-1 (KRAS G12D) cells (Figure 1B), which were derived from patients with malignant ascites (17–19).